Patent details

EP3522872 Title: AMLODIPINE FORMULATIONS

Basic Information

Publication number:
EP3522872
PCT Application Number:
US2017055576
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP178592697
PCT Publication Number:
WO2018067959
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AMLODIPINE FORMULATIONS
French Title of Invention:
FORMULATIONS D'AMLODIPINE
German Title of Invention:
AMLODIPINFORMULIERUNGEN
SPC Number:

Dates

Filing date:
06/10/2017
Grant date:
11/08/2021
EP Publication Date:
14/08/2019
PCT Publication Date:
12/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/08/2021
EP B1 Publication Date:
11/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/10/2021
Expiration date:
06/10/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
04/08/2021
 
 

Name:
Silvergate Pharmaceuticals, Inc.
Address:
6251 Greenwood Plaza Blvd. Suite 101, Greenwood Village, CO 80111, United States (US)

Inventor

1

Name:
BRAUER, Scott
Address:
United States (US)

2

Name:
MOSHER, Gerold L.
Address:
United States (US)

Priority

Priority Number:
201662405455 P
Priority Date:
07/10/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/10; A61K 47/02; A61K 47/12; A61K 47/26; A61K 47/34; A61K 47/38; A61P 9/12; A61K 31/4422;

Publication

European Patent Bulletin

1

Issue number:
202132
Publication date:
11/08/2021
Description:
Grant (B1)

2

Issue number:
202137
Publication date:
15/09/2021
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages